Hepatitis C virus in sub-Saharan Africa: a long road to elimination

Shah, R. et al. (2021) Hepatitis C virus in sub-Saharan Africa: a long road to elimination. Lancet Gastroenterology and Hepatology, 6(9), pp. 693-694. (doi: 10.1016/S2468-1253(21)00224-7) (PMID:34391525)

Abstract

The development of direct-acting antivirals against hepatitis C virus (HCV) has transformed the treatment landscape and underpinned the WHO goal of HCV elimination by 2030. However, as of 2021, few countries remain on track to achieve this goal. Reliable data remain scarce, especially those on national plans for HCV elimination in many regions of the world and particularly in sub-Saharan Africa, which accounts for around 11 million of 71 million people estimated to be living with HCV.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Shah, Dr Rajiv and Thomson, Professor Emma
• Authors: Shah, R., Agyei-Nkansah, A., Alikah, F., Asamoah-Akuoko, L., Bagou, Y. C. O., Dhiblawe, A., Ehichioya, D., Finch, P. J., Katsidzira, L., Kodjoh, N., Kpossou, R. A., Lakoh, S., Makuza, J. D., Marowa, L., Ndububa, D. A., Mbendi, C. N., Nyirenda, M., Ocama, P., Opio, C. K., Seremba, E., Shindano, T. A., and Thomson, E. C.
• College/School: College of Medical Veterinary and Life Sciences > School of Infection & Immunity; College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research
• Journal Name: Lancet Gastroenterology and Hepatology
• Publisher: Elsevier
• ISSN: 2468-1253
• ISSN (Online): 2468-1156
• Published Online: 12 August 2021
• Copyright Holders: Copyright © 2021 Elsevier Ltd.
• First Published: First published in Lancet Gastroenterology and Hepatology 6(9): 693-694
• Publisher Policy: Reproduced in accordance with the publisher copyright policy